Featured products

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC7083	Bi 2536 Featured	BI2536 is a potent Plk1 inhibitor with IC50 of 0.83 nM, BI2536 shows 4- and 11-fold greater selectivity against Plk2 and Plk3; BI2536 also is a BRD4 inhibitor(IC50= 25 nM).
DC20779	BI-3802 Featured	BI-3802 (BI3802) is a highly potent and effective BCL6 degrader that disrupts the interaction between the BTB/POZ domain of BCL6 and its co-repressors in vitro, achieving an IC50 of less than 3 nM.
DC23310	BI-3812 Featured	BI-3812 is potent and efficacious BCL6 inhibitor, inhibiting the BTB domain of BCL6, with an IC50 of ≤3 nM; BI-3812 has antitumor activity.
DC22310	BI-4464 Featured	BI-4464 (BI 4464) is a potent, highly selective, ATP competitive inhibitor of Focal adhesion tyrosine kinase (PTK2/FAK) with IC50 of 17 nM..
DC11960	BI605906 Featured	BI605906 is a potent, specific IKKβ inhibitor with IC50 of 380 nM (0.1 mM ATP), does not suppress signaling downstream of mTOR or activate AMPK.
DC7107	BI-78D3 Featured	BI-78D3 is a competitive c-Jun N-terminal kinase (JNK) inhibitor (IC50 = 280 nM) that displays > 100 fold selectivity over p38α and no activity at mTOR and PI-3K.
DC8401	BI-847325 Featured	BI-847325 is an orally bioavailable, and selective dual MEK/Aurora kinase inhibitor with IC50 of 3 nM, 25 nM, 15 nM, 25 nM, and 4 nM for Xenopus laevis Aurora B, human Aurora A and Aurora C, as well as human MEK1 and MEK2, respectively. Phase 1.
DC9888	BI-9564 Featured	BI-9564 is a selective, and cell-permeable BRD9 BD inhibitor, with Kd of 5.9 nM for BRD9, and IC50 of > 100 μM for BET family.
DC10404	BIA 10-2474 Featured	BIA 10-2474 is an inhibitor of fatty acid amide hydrolase (FAAH) with IC50 values of 50 to 70mg/kg in various rat brain regions.
DC20788	BIBO-3304 Featured	BIBO 3304 is a potent, selective, nonpeptide neuropeptide Y Y1 receptor antagonist with IC50 of 0.38 and 0.72 nM for human and the rat Y1 receptor, respectively.
DC7085	BIBR-1532 Featured	BIBR 1532 is a potent, selective, non-competitive telomerase inhibitor with IC50 of 100 nM.
DCAPI1112	BIBR 953(Dabigatran) Featured	BIBR 953 (Dabigatran, Pradaxa) is a highly selective, reversible, and potent thrombin inhibitor and is orally available as the prodrug, dabigatran etexilate.
DC1010	BIBR-1048 (Dabigatran etexilate) Featured	BIBR-1048 (Dabigatran) represents a breakthrough in anticoagulant therapy as a potent, selective direct thrombin inhibitor.
DC9670	BIBS39 Featured	BIBS 39 is a new nonpeptide angiotensin II (AII) receptor antagonist.
DC1024	Afatinib (BIBW2992) Featured	BIBW2992 (Afatinib, Tomtovok, Tovok) irreversibly inhibits EGFR/HER2 including EGFRwt, EGFRL858R, EGFRL858R/T790M and HER2 with IC50 of 0.5 nM, 0.4 nM, 10 nM and 14 nM, respectively.
DC10890	Bictegravir Featured	Bictegravir is a novel, potent inhibitor of HIV-1 integrase with an IC50 of 7.5 nM.
DC7098	BI-D1870 Featured	BI-D1870 is a small molecule, specific inhibitor of p90 RSK (ribosomal S6 kinase) isoforms RSK1, RSK2, RSK3 and RSK4, both in vitro and in vivo, with IC50s are 31 nM, 24 nM, 18 nM, 15 nM, respectively.
DC7086	BIIB021(CNF2024) Featured	BIIB021(CNF2024) is an orally available, fully synthetic small-molecule inhibitor of HSP90 with Ki and EC50 of 1.7 nM and 38 nM, respectively.
DC8263	Bikinin Featured	Bikinin is a strong activator of brassinosteroid (BR) signaling.
DC7995	Bilastine Featured	Bilastine is a selective histamine H1 receptor antagonist used for treatment of allergic rhinoconjunctivitis and urticaria.
DC22281	Bilobalide Featured	Bilobalide is a sesquiterpene lactone which is found in extracts of G. biloba.
DCAPI1079	Bimatoprost Featured	Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension.
DC6801	Bindarit Featured	Bindarit exhibits selective inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.
DC7663	BIO Featured	BIO (6-bromoindirubin-3'-oxime) is a specific inhibitor of GSK-3 with IC50 of 5 nM for GSK-3α/β, shows >16-fold selectivity over CDK5, also a pan-JAKinhibitor.
DC8368	BIO-acetoxime Featured	BIO-Acetoxime is an analog of the GSK3 inhibitor 6-bromoindirubin-3’-oxime, or BIO
DC7603	Bioymifi Featured	Bioymifi(DR5 Activator) is the first novel and potent small-molecule activatior of the TRAIL receptor DR5 in human cancer cells.
DC25079	Biperiden hydrochloride Featured	Biperiden Hcl (NSC 170950, NSC 84989) is a centrally-acting antiparkinsonian agent that functions as a selective central M1 cholinoreceptors blocker..
DC7836	Doramapimod (BIRB-796) Featured	BIRB 796 (Doramapimod) is a highly selective p38α MAPK inhibitor with Kd of 0.1 nM, 330-fold greater selectivity versus JNK2, weak inhibition for c-RAF, Fyn and Lck, insignificant inhibition of ERK-1, SYK, IKK2, ZAP-70, EGFR, HER2, PKA, PKC, PKCα/β/γ.
DC5023	Birinapant (TL32711) Featured	Birinapant (TL32711) is a SMAC mimetic antagonist, mostly to cIAP1 with Kd of <1 nM, less potent to XIAP.
DC10863	Bis(tributylammonium) difluoromethylenediphosphonate Featured	Bis(tributylammonium) difluoromethylenediphosphonate

Featured products

Customized Consultation X

Your information is safe with us. * Required Fields.